129
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Peri-Procedural Blood Pressure Changes and Their Relationship with MACE in Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study

ORCID Icon, & ORCID Icon
Pages 187-195 | Published online: 10 Dec 2020

References

  • Coronary Heart Disease Statistics. British Heart Foundation. Published 13/ 12/2012.resource code: G 608/1012/CHA. 2012.
  • Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2013;34(39):3028–3034. doi:10.1093/eurheartj/eht35624014390
  • Levy LB. Dietary strategies, policy and cardiovascular disease risk reduction in England. Proc Nutr Soc. 2013;72(4):386–389. doi:10.1017/S002966511300132823842106
  • Who, The world health report. Reducing Risks, Promoting Healthy Life. World Health Organization; 2002.
  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi:10.1016/S0140-6736(06)68770-916731270
  • Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies. The story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51(7):701–707. doi:10.1016/j.jacc.2007.10.03418279733
  • Grayson AD, Moore RK, Jackson M, et al; North West Quality Improvement Programme in Cardiac Interventions. Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England. Heart. 2006;92(5):658–663. doi:10.1136/hrt.2005.06641516159983
  • Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937‐952. doi:10.1016/S0140-6736(04)17018-9
  • Ishii S, Inomata T, Ikeda Y, et al. Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in non ischemic dilated cardiomyopathy. Heart Vessels. 2014;29:88–96. doi:10.1007/s00380-013-0335-023519525
  • Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 2014;100:153–159.24270744
  • Kolloch R, Legler UF, Champion A, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J. 2008;29(10):1327‐1334. doi:10.1093/eurheartj/ehn123
  • Thygesen K, Alpert JS, White HD, et al.; Task Force Members, ESC Committee for Practice Guidelines, Document Reviewers. Universal definition of myocardial infarction: kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Eur Heart J. 2007;28(20):2525–2538. doi:10.1093/eurheartj/ehm35517951287
  • Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; Council on cardiovascular surgery and anesthesia; Council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. Stroke. 2009;40:2276–2293.19423857
  • Cho KI, Ann SH, Singh GB, Her AY, Shin ES. Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous. PLoS One. 2015;10(7):e 0133934. doi:10.1371/journal.pone.0133934
  • Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol. 2011;58(54):e 44–122. doi:10.1016/j.jacc.2011.08.007
  • Lingman M, Albertsson P, Herlitz J, Bergfeldt L, Lagerqvist B. The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary intervention. Am J Med. 2011;124(3):265‐275. doi:10.1016/j.amjmed.2010.09.015
  • Spyridopoulos I, Noman A, Ahmed JM, et al. Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2015;4(3):270‐277. doi:10.1177/2048872614561480
  • Bordejevic DA, Caruntu F, Mornos C, et al. Prognostic impact of blood pressure and heart rate at admission on in-hospital mortality after primary percutaneous intervention for acute myocardial infarction with ST-segment elevation in western Romania. Ther Clin Risk Manag. 2017;13:1061–1068. doi:10.2147/TCRM.S14131228883734
  • Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23(23):1809–1840. doi:10.1053/euhj.2002.338512503543
  • Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. J Am Med Assoc. 2006;296(18):2217–2226. doi:10.1001/jama.296.18.2217
  • Pitsavos C, Panagiotakos DB, Zombolos S, et al. Systolic blood pressure on admission predicts in-hospital mortality among patients presenting with acute coronary syndromes: the Greek study of acute coronary syndromes. J Clin Hypertens. 2008;10:362–366. doi:10.1111/j.1751-7176.2008.07619.x
  • Shiraishi J, Kohno Y, Sawada T, et al. Systolic blood pressure at admission, clinical manifestations, and in-hospital outcomes in patients with acute myocardial infarction. J Cardiol. 2011;58:54–60. doi:10.1016/j.jjcc.2011.04.00321621980
  • Fox KAA, Gore JM, Eagle KA, et al. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190–199.11174331
  • The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682. doi:10.1056/NEJM1993090232910018204123
  • Topol EJ. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II b. N Engl J Med. 1996;335(11):775–782.8778585
  • Braunwald E, Neuhaus KL, Antman E, et al. Intravenous lanoteplase for the treatment of infarcting myocardium early: in TIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005–2013.11102251
  • Krumholz HM, Chen J, Wang Y, Radford MJ, Chen YT, Marciniak TA. Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk-adjustment. Circulation. 1999;99(23):2986–2992. doi:10.1161/01.CIR.99.23.298610368115
  • Williams BA, Wright RS, Murphy JG, Brilakis ES, Reeder GS, Jaffe AS. A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emerg Med J. 2006;23:186–192. doi:10.1136/emj.2005.02732616498154
  • Pogorevici A, Citu IM, Bordejevic DA, Caruntu F, Tomescu MC. Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania. Clin Interv Aging. 2016;11:481–488.27217732
  • Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736–749. doi:10.1093/oxfordjournals.aje.a1130467457467